AssetMark’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$44.3K Buy
202
+5
+3% +$1.11K ﹤0.01% 1937
2026
Q2
$41.6K Buy
197
+18
+10% +$3.3K ﹤0.01% 1897
2026
Q1
$28.6K Buy
179
+25
+16% +$3.84K ﹤0.01% 1937
2025
Q4
$21.1K Sell
154
-62
-29% -$8.01K ﹤0.01% 1982
2025
Q3
$26.2K Sell
216
-1
-0.5% -$108 ﹤0.01% 1844
2025
Q2
$23.2K Sell
217
-51
-19% -$5.1K ﹤0.01% 1771
2025
Q1
$24.9K Buy
268
+83
+45% +$8.04K ﹤0.01% 1647
2024
Q4
$19.9K Buy
185
+34
+23% +$4.14K ﹤0.01% 1656
2024
Q3
$19K Buy
151
+139
+1,158% +$17.5K ﹤0.01% 1504
2024
Q2
$1.3K Buy
+12
New +$1.17K ﹤0.01% 1817

Other funds holding NHC

AssetMark's NHC Position: Q3 2026 in Review

AssetMark increased its National Healthcare (NHC) stake by 2.5% in Q3 2026, buying an estimated $1.11K and bringing the position to 202 shares worth $44.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1937.

AssetMark first reported a position in NHC in Q2 2024 and has held it in 10 quarters since. 223 funds tracked by Wall St. Rank hold NHC as of Q3 2026.

  • AssetMark held 202 shares of National Healthcare worth $44.3K as of Q3 2026.
  • AssetMark bought 5 National Healthcare shares in Q3 2026, an estimated $1.11K.
  • National Healthcare made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #1937 holding.
  • AssetMark first reported a position in National Healthcare in Q2 2024 and has held it in 10 quarters since.
  • 223 funds tracked by Wall St. Rank held National Healthcare as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.